Marsh Q3 2026: 5% Underlying Revenue Growth, Adjusted EPS Up 10% to $2.03
MRSH sits 15% above its 52-week low of $156.6.
Summary
Marsh reported Q3 2026 revenue of $6.9B (up 8% GAAP, 5% underlying) and adjusted EPS of $2.03 (up 10%), with $500M in buybacks and a $144M Greensill charge.
Key Events · Earnings and Guidance · MRSH
-
Q3 Revenue Grows 5% Underlying
Consolidated revenue of $6.863B, up 8% GAAP and 5% underlying, with Management Consulting up 14% and Risk up 5% underlying.
-
Adjusted EPS Rises 10% to $2.03
Q3 GAAP EPS of $1.69; adjusted EPS of $2.03, up 10% year-over-year. Nine-month adjusted EPS of $8.29, up 9%.
-
$500M Buyback in Q3
Repurchased 2.7M shares for $500M in Q3; 11.4M shares for $2.0B through nine months.
-
Greensill Charge of $144M
Q3 included $144M in Greensill litigation settlement and legal expenses, net of insurance recoveries; $569M for nine months.
Analysis · MRSH · Finance
Marsh delivered a solid third quarter, with 5% underlying revenue growth and 10% adjusted EPS growth to $2.03. Management Consulting's 14% revenue jump and Risk's 5% underlying growth drove the top line. The company also repurchased $500M of stock in the quarter and repaid €550M of maturing notes, signaling balance sheet strength. However, the Greensill litigation remains a drag with a $144M charge in the quarter, and Reinsurance revenue declined 6%. The results support the thesis of a resilient, cash-generative business, but the legal overhang and soft reinsurance segment temper the upside.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.2% of the 2653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MRSH was trading at $180.50 on NYSE in the Finance sector, with a market capitalization of approximately $85.1B. The 52-week trading range was $156.60 to $207.28. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.